Conclusion In conclusion, the study shows that 24 weeks of semaglutide treatment significantly reduced albuminuria in patients with CKD and obesity, with an acceptable safety profile
Decisions about treatment duration should be personalized and made in consultation with a healthcare provider
Heres why Cellular Prime liposomal products have an edge over traditional supplements: Nano Liposomal Delivery: Nano liposomal phospholipid vesicles help protect glutathione throughout the digestive tract for efficient uptake into your cells
The acetyl in nutrition: whats its role
For people who are overweight or living with obesity and an autoimmune disease, this study offers a hopeful signal that medications already in use today may be beneficial in reducing their risk of cardiovascular disease.More informationThe Mayo Clinic has more on GLP-1 drug benefits.SOURCE: American Heart Association, news release, June 6, 2026 .What This Means For YouPeople with autoimmune diseases and obesity should ask their doctor about GLP-1 drugs..Sign up for our weekly HealthDay newsletter
Energy & Wellness May improve energy levels, mental clarity, and overall vitality
